These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 34279484)

  • 1. Fibrin Clot Properties in Atherosclerotic Vascular Disease: From Pathophysiology to Clinical Outcomes.
    Ząbczyk M; Natorska J; Undas A
    J Clin Med; 2021 Jul; 10(13):. PubMed ID: 34279484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibrin clot properties in cardiovascular disease: from basic mechanisms to clinical practice.
    Ząbczyk M; Ariëns RAS; Undas A
    Cardiovasc Res; 2023 Mar; 119(1):94-111. PubMed ID: 36662542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma fibrin clot structure and thromboembolism: clinical implications.
    Ząbczyk M; Undas A
    Pol Arch Intern Med; 2017 Dec; 127(12):873-881. PubMed ID: 29225327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acquired dysfibrinogenemia in atherosclerotic vascular disease.
    Undas A
    Pol Arch Med Wewn; 2011 Sep; 121(9):310-9. PubMed ID: 21952526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antithrombotic medications and their impact on fibrin clot structure and function.
    Undas A; Zabczyk M
    J Physiol Pharmacol; 2018 Aug; 69(4):. PubMed ID: 30415236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered fibrin clot properties and fibrinolysis in patients with atrial fibrillation: practical implications.
    Undas A
    Europace; 2020 Feb; 22(2):185-194. PubMed ID: 31625555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Denser plasma clot formation and impaired fibrinolysis in paroxysmal and persistent atrial fibrillation while on sinus rhythm: association with thrombin generation, endothelial injury and platelet activation.
    Drabik L; Wołkow P; Undas A
    Thromb Res; 2015 Aug; 136(2):408-14. PubMed ID: 26048399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prothrombotic state and denser clot formation in patients following acute limb ischemia of unknown cause.
    Karpińska IA; Nowakowski T; Wypasek E; Plens K; Undas A
    Thromb Res; 2020 Mar; 187():32-38. PubMed ID: 31951936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma Fibrin Clot Properties Are Unfavorably Altered in Women following Venous Thromboembolism Associated with Combined Hormonal Contraception.
    Piróg M; Piwowarczyk S; Undas A
    Dis Markers; 2019; 2019():4923535. PubMed ID: 31827635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unfavorably Altered Fibrin Clot Properties in Patients with Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss Syndrome): Association with Thrombin Generation and Eosinophilia.
    Mastalerz L; Celińska-Lӧwenhoff M; Krawiec P; Batko B; Tłustochowicz W; Undas A
    PLoS One; 2015; 10(11):e0142167. PubMed ID: 26540111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombosis and Aging: Fibrin Clot Properties and Oxidative Stress.
    Konieczyńska M; Natorska J; Undas A
    Antioxid Redox Signal; 2024 Aug; 41(4-6):233-254. PubMed ID: 38062775
    [No Abstract]   [Full Text] [Related]  

  • 12. Prothrombotic fibrin clot properties are associated with post-discharge venous thromboembolism in acutely ill medical patients.
    Wójcik M; Zaręba L; Undas A
    Thromb Res; 2019 Oct; 182():141-149. PubMed ID: 31479942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered fibrin clot structure/function in patients with antiphospholipid syndrome: association with thrombotic manifestation.
    Celińska-Lowenhoff M; Iwaniec T; Padjas A; Musiał J; Undas A
    Thromb Haemost; 2014 Aug; 112(2):287-96. PubMed ID: 24652596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrin clot properties in acute ischemic stroke: relation to neurological deficit.
    Undas A; Slowik A; Wolkow P; Szczudlik A; Tracz W
    Thromb Res; 2010 Apr; 125(4):357-61. PubMed ID: 19942259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clot properties and cardiovascular disease.
    Bridge KI; Philippou H; Ariëns R
    Thromb Haemost; 2014 Nov; 112(5):901-8. PubMed ID: 24899357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imbalance between Fibrin Clot Formation and Fibrinolysis Predicts Cardiovascular Events in Patients with Stable Coronary Artery Disease.
    Neergaard-Petersen S; Larsen SB; Grove EL; Kristensen SD; Ajjan RA; Hvas AM
    Thromb Haemost; 2020 Jan; 120(1):75-82. PubMed ID: 31733633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolonged duration of type 2 diabetes is associated with increased thrombin generation, prothrombotic fibrin clot phenotype and impaired fibrinolysis.
    Konieczynska M; Fil K; Bazanek M; Undas A
    Thromb Haemost; 2014 Apr; 111(4):685-93. PubMed ID: 24306139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction therapy alters plasma fibrin clot properties in multiple myeloma patients: association with thromboembolic complications.
    Undas A; Zubkiewicz-Usnarska L; Helbig G; Woszczyk D; Kozińska J; Dmoszyńska A; Dębski J; Podolak-Dawidziak M; Kuliczkowski K
    Blood Coagul Fibrinolysis; 2015 Sep; 26(6):621-7. PubMed ID: 26083985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered plasma fibrin clot properties and fibrinolysis in patients with multiple myeloma.
    Undas A; Zubkiewicz-Usnarska L; Helbig G; Woszczyk D; Kozińska J; Dmoszyńska A; Podolak-Dawidziak M; Kuliczkowski K
    Eur J Clin Invest; 2014 Jun; 44(6):557-66. PubMed ID: 24738991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibrin clot structure and function: a role in the pathophysiology of arterial and venous thromboembolic diseases.
    Undas A; Ariëns RA
    Arterioscler Thromb Vasc Biol; 2011 Dec; 31(12):e88-99. PubMed ID: 21836064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.